Limfoma non-Hodgkin Dokter Terbaik di Israel - TOP-20 dokter

Dr. Ram Ron adalah Direktur Unit Transplantasi Sumsum Tulang di departemen onko-hematologi Sourasky Medical Center.

• Menjalani pelatihan di Fred Hutchinson Cancer Research Center yang terkemuka di Amerika Serikat
• Spesialisasi dalam hematologi dan transplantasi sumsum tulang untuk kanker darah
• Sertifikasi dewan dalam penyakit dalam, hematologi, dan transplantasi sumsum tulang
• Pengalaman klinis lebih dari satu dekade di lembaga hematologi utama di Israel

Dr. Ron Ram telah melakukan beberapa ratus transplantasi sel punca, sebuah pengobatan utama untuk limfoma Non-Hodgkin, di Sourasky Medical Center (Ichilov).

• Tersertifikasi dalam Hematologi, Onkologi Medis, dan Penyakit Dalam
• Menulis lebih dari 30 artikel ilmiah dan bab buku teks di bidang tersebut
• Menyelesaikan fellowship Hematologi dan Onkologi di New York Medical College
• Pelatihan residensi di State University of New York di Brooklyn

Dr. El Hasid telah melakukan lebih dari 300 transplantasi sumsum tulang dan darah tali pusat untuk anak-anak, serta mengepalai departemen di Rumah Sakit Anak Dana Dwek.

• Mengkhususkan diri secara eksklusif dalam onkohematologi dan onkologi pediatrik
• Penulis 50 publikasi ilmiah dan 40 laporan konferensi
• Anggota American Society of Hematology
• Menjalani pelatihan dan praktik di Rumah Sakit City of Hope yang bergengsi di Los Angeles
• Anggota Masyarakat Israel untuk Hemato-Onkologi Pediatrik

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Seorang spesialis senior transplantasi sumsum tulang untuk limfoma Non-Hodgkin, Dr. Shapira dilatih di salah satu pusat medis terkemuka di Israel.

• Pengalaman lebih dari 20 tahun di bidang hematologi
• Spesialisasi dalam penyakit dalam di Hadassah Medical Center
• Dokter senior di departemen Transplantasi Sumsum Tulang
• Berfokus pada pendekatan pengobatan yang kompleks ini

6 tahun di Memorial Sloan Kettering Cancer Center – Dr. Joffe berspesialisasi dalam pengobatan limfoma dan CLL di Sourasky Medical Center.

• Pelatihan subspesialisasi lanjutan dalam limfoma dan CLL
• Mengelola studi klinis pada obat-obatan baru dan imunoterapi
• Anggota kelompok dokter perawatan limfoma langka
• Dokter senior di bidang Hematologi dan Transplantasi Sumsum Tulang

Dengan 31 tahun fokus pada onkohematologi, Dr. Aviv membawa keahlian mendalam dalam menangani limfoma Non-Hodgkin di Klinik Ichilov.

• Spesialisasi dalam kanker darah dan kondisi hematologi yang kompleks
• Bekerja di Sourasky Medical Center – rumah sakit onkologi terkemuka
• Berdedikasi pada pendekatan perawatan yang personal bagi setiap pasien

Dr. Dror Levin mengepalai departemen hematologi onkologi anak di Sourasky Medical Center – seorang ahli terkemuka dalam kelainan darah pediatrik.

• Spesialisasi dalam mengobati kanker tulang dan jaringan lunak (sarkoma) pada anak-anak
• Sertifikasi dewan dalam hematologi dan onkologi pediatrik
• Pelatihan di Rizzoli Orthopaedic Institute – pemimpin dunia dalam onkologi tulang
• Anggota Masyarakat Hematologi-Onkologi Pediatrik Israel
• Mengkoordinasikan program perawatan untuk gangguan pembekuan darah pada anak-anak

Dr. Yair telah memberikan kontribusi signifikan dalam bidang hematologi, khususnya pada leukemia limfositik kronis, dengan berbagai penghargaan dan penelitian yang diterbitkan.

• Penerima berbagai penghargaan bergengsi, termasuk Young Investigator Research Prize dan Klitzberg Oncology Award
• Anggota dari Asosiasi Hematologi Israel dan Amerika
• Pelatihan ekstensif dalam hematologi di Tel Aviv Medical Center
• Peneliti yang karyanya telah dipublikasikan dengan dana hibah dari Israeli Science Foundation dan lembaga lainnya

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Ofer Spielberg adalah seorang onkolog yang berspesialisasi dalam limfoma Non-Hodgkin di Assuta Medical Center.

• Fokus pada metode diagnostik tingkat lanjut dan protokol perawatan yang disesuaikan
• Mengintegrasikan penelitian klinis terbaru ke dalam praktik bedah
• Tersedia untuk memberikan saran mengenai kasus limfoma rutin maupun kompleks

Diakui oleh Forbes sebagai salah satu dokter terbaik pada tahun 2018 – Dr. Stepensky telah melakukan lebih dari 3.500 transplantasi sumsum tulang di Hadassah Medical Center.

• Berpengalaman selama 20 tahun di bidang hematologi pediatrik
• Spesialisasi dalam mengobati anak-anak dengan kanker darah langka
• Dikenal di kalangan pasien sebagai 'sosok yang mentransplantasikan kehidupan'
• Bekerja di Hadassah Medical Center – rumah sakit terkemuka di Israel

Professor Zila Zuckerman berspesialisasi dalam hematologi dan transplantologi di Rambam Medical Center.

• Keahlian dalam pengobatan limfoma Non-Hodgkin
• Berspesialisasi dalam hematologi dan transplantologi
• Bekerja di Rambam Medical Center

Spesialisasi khusus dalam hematologi dengan fokus pada pengobatan limfoma. Ia berpraktik di Rambam Medical Center – sebuah rumah sakit terkemuka di Israel.

• Memberikan fokus khusus pada perawatan kompleks yang dibutuhkan limfoma
• Memiliki pengetahuan mendalam tentang pengobatan dan protokol khusus limfoma
• Spesialisasi hematologinya menjamin perawatan terkini untuk kanker darah